MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
J15
29 active Medicare policies list Z79.4, and 2 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15
J5
J8
J15 · Effective Aug 10, 2026
JE · Effective Aug 10, 2026
JF · Effective Aug 10, 2026
JJ · Effective Aug 10, 2026
2 policies from 1 payer
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of Z79.4 |
|---|---|---|
| Outpatient Glycated Hemoglobin and Protein Testing | Jul 1, 2026 | Covered |
| Pancreas Transplantation and Pancreas Kidney Transplantation | Oct 1, 2026 | Covered |
JM · Effective Aug 10, 2026
J5 · Effective Aug 10, 2026
J8 · Effective Aug 10, 2026
JE · Effective Mar 13, 2017
JF · Effective Mar 13, 2017
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J6 · Effective Apr 1, 2018
JK · Effective Apr 1, 2018
JE · Effective Feb 3, 2017
JF · Effective Feb 3, 2017
National · Effective Apr 17, 2025
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
J6 · Effective Apr 1, 2026
National · Effective Nov 6, 2025
National · Effective Aug 14, 2025
J6 · Effective Apr 1, 2026